Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00639717
What this trial is testing

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
University of Michigan Rogel Cancer Center 48
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Not applicableUnknownNCT06394895
What this trial is testing

Donor Neutrophil Subsets to Predict the Risk of aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Study completedNCT03082677
What this trial is testing

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Myeloid Hematologic MalignancyLymphoid Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Testing effectiveness (Phase 2)Study completedNCT01175148
What this trial is testing

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Who this might be right for
Graft vs Host Disease
West Virginia University 60
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Not applicableStudy completedNCT01369914
What this trial is testing

The Natural History of Graft-Versus-Host Disease in the Eyes

Who this might be right for
Graft-Versus-Host Disease
National Eye Institute (NEI) 61
Large-scale testing (Phase 3)Active Not RecruitingNCT06294678
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Not applicableStudy completedNCT01520623
What this trial is testing

Complement and Graft-versus-host Disease

Who this might be right for
Allografted With Myeloablative Conditioning
Assistance Publique - Hôpitaux de Paris 70
Early research (Phase 1)Study completedNCT00005988
What this trial is testing

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT01518153
What this trial is testing

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT02105766
What this trial is testing

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

Who this might be right for
Sickle Cell DiseaseThalassemiaStem Cell Transplantation+1 more
National Heart, Lung, and Blood Institute (NHLBI) 56
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Testing effectiveness (Phase 2)UnknownNCT03297528
What this trial is testing

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Who this might be right for
Donor Lymphocyte InfusionAllogeneic Hematopoietic Stem Cell TransplantationAcute Leukemia+3 more
Peking University People's Hospital 40
Large-scale testing (Phase 3)Study completedNCT00993343
What this trial is testing

Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseSurvival
Karolinska Institutet 215
Post-approval studies (Phase 4)Study completedNCT01883180
What this trial is testing

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell TransplantationAntithymocyte GlobulinViral Infection
Nanfang Hospital, Southern Medical University 412
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT04014790
What this trial is testing

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute-graft-versus-host Disease+1 more
Regimmune Corporation 49
Not applicableUnknownNCT03148197
What this trial is testing

Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)

Who this might be right for
Acute Myeloid LeukemiaGraft-versus-host-diseaseAllogeneic Hematopoietic Stem Cell Transplantation+1 more
University of Cologne 120
Next Page
64